Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by GW&K Investment Management LLC

GW&K Investment Management LLC cut its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 2.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 790,721 shares of the company's stock after selling 22,997 shares during the quarter. GW&K Investment Management LLC owned 0.86% of Acadia Healthcare worth $61,486,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Headlands Technologies LLC bought a new position in shares of Acadia Healthcare during the 3rd quarter worth approximately $25,000. GAMMA Investing LLC purchased a new position in Acadia Healthcare in the fourth quarter worth $26,000. Fifth Third Bancorp grew its stake in Acadia Healthcare by 25.5% in the 4th quarter. Fifth Third Bancorp now owns 670 shares of the company's stock valued at $52,000 after purchasing an additional 136 shares during the period. DekaBank Deutsche Girozentrale purchased a new stake in shares of Acadia Healthcare during the 3rd quarter valued at $96,000. Finally, Oak Thistle LLC bought a new stake in shares of Acadia Healthcare during the 4th quarter worth $235,000.

Analyst Ratings Changes

A number of analysts recently issued reports on the stock. Royal Bank of Canada restated an "outperform" rating and set a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. Bank of America dropped their price objective on Acadia Healthcare from $105.00 to $90.00 and set a "buy" rating on the stock in a research note on Thursday, May 2nd. Barclays decreased their target price on Acadia Healthcare from $91.00 to $89.00 and set an "overweight" rating for the company in a research report on Wednesday, May 15th. StockNews.com raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Monday, May 13th. Finally, TheStreet raised Acadia Healthcare from a "c" rating to a "b-" rating in a report on Monday, March 4th. Four analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $87.56.

Acadia Healthcare Price Performance

ACHC stock traded up $0.44 during mid-day trading on Monday, reaching $66.79. 648,916 shares of the company traded hands, compared to its average volume of 667,009. Acadia Healthcare Company, Inc. has a 52-week low of $64.74 and a 52-week high of $87.77. The company has a market capitalization of $6.20 billion, a P/E ratio of -477.04, a P/E/G ratio of 1.97 and a beta of 1.31. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The company has a fifty day moving average price of $73.38 and a 200-day moving average price of $77.10.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. The business had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. Acadia Healthcare's revenue was up 9.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.75 EPS. As a group, analysts anticipate that Acadia Healthcare Company, Inc. will post 3.55 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Wade D. Miquelon sold 2,203 shares of the company's stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now directly owns 46,074 shares in the company, valued at $3,934,258.86. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.00% of the stock is owned by company insiders.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.